Theralase Technologies Inc. V.TLT

Adstiladrin has BlockBuster Potential...

[wildbird1]

In this link...
https://fiercepharma.com/pharma/ferring-inks-500m-deal-royalty-pharma-new-bladder-cancer-drug-adstiladrin

Paragraph #7...
The CEO of Royalty Pharma, Pablo Legorreta said " Adstiladrin has BlockBuster Potential".

Adstiladrin...
- Adstiladrin has a 24%CR at 12 months.
- Adstiladrin has minimal side effects.
- Adstiladrin has one big restriction, Adstiladrin can not treat patients that are immunocompromised, that is a big restriction, because many older cancer patients are immunocompromised.

TLT-Ruvidar...
- Ruvidar has a 38%CR at 12 months(optimised patients).
- Ruvidar has minimal side effects.
- Unlike Adstiladrin, Ruvidar can treat any kind of patients including immunocompromised patients.
- And to top it off, it cost less to treat a cancer patient with Ruvidar.

As we speak ours new independant director, Dr Lbiati with these data in hand must have a pleasant time " commencing to actively explore international partnering".

According to this article Adstiladrin with 24%CR at 12 months and a big immunocompromised restriction is worth $500 milllion US.

With 38%CR at 12 months(optimised) and no restrictions, how much is TLT-Ruvidar worth $$$$$????.

You have to love the BlockBuster Potential of your TLT shares.

[Oilminerdeluxe]

Wiping my jaws from saliva as we speak :-)

[riverrrow]

Plus the name Ruvidar is so much easier to say and remember than Adstiladrin.  Branding alone should be worth a couple of hundred million.

[socksnblonds642]

Could even be the name of a movie. 

[wildbird1]

Forgot a very important detail, a big pharma will only sign a deal after the FDA has approved a treatment(not before). Adstiladrin is approved by the FDA(Ruvidar is not). In short big pharma are not gamblers. After the undeniable approval of TLT-Ruvidar by the FDA , multiple big pharma deals will materialize. Until then we have to accept the fact that the SP will stagnate.

[socksnblonds642]

Probably not a great comparison on a few fronts. The 500 million dollar deal was to a multi product multi national company that has bricks and mortar in many countries. They've also been in business for 70 years. They had the global infrastructure in place. The 500 million is for a piece of the action. At 160k-260k a treatment they have a huge revenue potential. They had the product AND the

[Legit62]

we are closing in on end of thrird quater, hopefully some good news soon

[Eoganacht]

Theralase also brings its IP to the table. It's unproven, as they have not had the resources to run trials for more cancer indications, but there is the potential for many effective cancer treatments for many kinds of cancer. If systemic instillation along with X-ray activation can be made to work who knows how many kinds of cancer can be treated? Plus there are other photosenstizers that Dr.

[Benedictus]

Yes, while at times I fret over the ongoing liquidity needs and the paltry private placements that come in dribs and drabs, it's worth remembering the bigger picture, which is why we are all here. An ideal roadmap would be ruvidar being granted BTD by Q1, or sooner. This achievement should hasten partner discussions/negotiations and result in a re-rating of the stock price bringing all

[DeathXray33]

I've increased my weekly buying program yet again at any price... Is Rog still buying?

[99942Apophis]

I picked up more today, when we’re this close its hard not to be greedy. Love TLT.

[patience69]

Eog What you say is so accurate. We all dream of the day that we reach that point. The problem of course is money to get there. Some say no to JV but how is that possible? To get to the achievements that you speak of takes lots of money that we dont have. It stands to be a very interesting next year or so. At what point does someone big say that they have enough proof? A bit to go yet I'm

[StevenBirch]

That's why BTD is really all that matters right now, the boost from that would be at least enough for warrant money to flow in and no JV would be done before BTD is granted. So we know from this last update we are at least in the window of likely within 3-4 months at the most. And Eog mentions the IP. Some have said TLT will either be $100 or zero but I disagree that this will ever be zero